Effect of Naoxintong capsule on clinical efficacy and inflammatory factors in patients with ischemic stroke

Objective To investigate the effect of Naoxintong capsule on clinical efficacy and inflammatory factors in patients with ischemic stroke. Methods 81 patients with ischemic stroke were divided into two groups according to random number table method.40 patients in the control group were treated with treatment guidelines, and the observation group was treated with another Naoxintong capsule.The serum interleukin-10(IL-10), tumor necrosis factor-a(TNF-α), high sensitivity C reactive protein(hs-CRP) level, National Institutes of Health Stroke Scale(NIHSS) and clinical efficacy of two groups were compared. Results After treatment, the hs-CRP, TNF-α levels of the observation group were (12.36±3.09)mg/L, (129.62±29.27)mg/L, which were lower than those of the control group[(16.71±4.29)mg/L, (186.52±37.62)ng/L, t=8.189, 5.287, all P<0.05). After treatment for 7d and 30d, the NIHSS scores of the observation group were (14.28±3.24)points, (5.23±1.47)points, which were lower than those of the control group[(18.76±4.53)points, (8.16±2.42)points, t=14.689, 12.827, all P<0.05]. IL-10 level of the observation group was (49.82±6.59)pg/mL, which was higher than (42.57±9.82)pg/mL of the control group (t=6.759, P<0.05). The total effective rate of the observation group was 92.68%, which was higher than 77.50% of the control group (χ2=4.897, P<0.05). Conclusion Naoxintong capsule has significant therapeutic effect on ischemic stroke, can effectively improve the inflammatory reaction after cerebral infarction, promote the recovery of neurological function and it is worthy of promotion. Key words: Naoxintong capsule; ischemic stroke; clinical efficacy; inflammatory factors